Skip to content

Comparison of antivenin and placebo effectiveness in scorpion biting

Comparison of antivenin and placebo effectiveness in scorpion biting

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138812142337N2
Enrollment
432
Registered
2010-03-05
Start date
2010-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scorpion bite. Venom of scorpion

Interventions

Intervention 1: Injection of a vial of placebo with identical shape as active antivenom. Intervention 2: Injection of a single dose of antivenin, a vial.
Placebo
Treatment - Drugs
Injection of a vial of placebo with identical shape as active antivenom
Injection of a single dose of antivenin, a vial

Sponsors

Vice-chancellor for Research, Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: scorpion biting Exclusion criteria: critically ill patients (shock, life threatening manifestations of scorpion biting)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Anaphylaxy. Timepoint: every 10 minute. Method of measurement: vital signs.;Improvement of symptoms. Timepoint: every 4 hours. Method of measurement: clinical presentation.;Adverse effects. Timepoint: every 4 hours. Method of measurement: blood and urine samples.

Secondary

MeasureTime frame
Serum sickness. Timepoint: During 1 week after injection of antivenom. Method of measurement: Physical examination and Fever.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBabak Mahshidfar

Iran University of Medical Sciences

bmahshidfar@yahoo.com+98 21 6651 8098

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026